{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:13:10Z","timestamp":1758708790541},"reference-count":11,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2007.01.051","type":"journal-article","created":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T16:42:40Z","timestamp":1169484160000},"page":"3175-3178","source":"Crossref","is-referenced-by-count":30,"title":["Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses"],"prefix":"10.1016","volume":"25","author":[{"given":"J.P.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.K.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.-Q.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.01.051_bib1","unstructured":"World Health Organization. http:\/\/www.who.int\/csr\/disease\/avian_influenza\/country\/cases_table_2006_11_13\/en\/index.html."},{"key":"10.1016\/j.vaccine.2007.01.051_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-4781(99)00147-5","article-title":"Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides","volume":"1489","author":"Krieg","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2007.01.051_bib3","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1128\/AAC.39.11.2574","article-title":"Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice","volume":"39","author":"Wong","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2007.01.051_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/infdis\/132.4.434","article-title":"A modified polyriboinosinic-polyribocyticylic acid complex that induces interferon in monkeys","volume":"132","author":"Levy","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.01.051_bib5","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0264-410X(98)00439-3","article-title":"Liposome-mediated immunotherapy against respiratory influenza virus infection using double stranded RNA poly ICLC","volume":"17","author":"Wong","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.051_bib6","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.vaccine.2005.01.037","article-title":"Prophylaxis of acute respiratory virus infection using nucleic acid-based drugs","volume":"23","author":"Wong","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.051_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/136.1.122","article-title":"Effect of a nuclease-resistant derivative of a polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta)","volume":"136","author":"Stephen","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.01.051_bib8","first-page":"503","article-title":"Prophylactic and therapeutic efficacy of poly (I,C)-LC against Rift Valley fever virus infection in mice","volume":"4","author":"Kende","year":"1985","journal-title":"J Biol Response Mod"},{"key":"10.1016\/j.vaccine.2007.01.051_bib9","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus","volume":"437","author":"Le","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.01.051_bib10","doi-asserted-by":"crossref","first-page":"16936","DOI":"10.1073\/pnas.0608157103","article-title":"Emergence and predominance of an H5N1 influenza variant in China","volume":"103","author":"Smith","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.01.051_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza (H5N1) is associated with high virus load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T19:52:33Z","timestamp":1547063553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":11,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X07000618"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}